CRSP icon

CRISPR Therapeutics

433 hedge funds and large institutions have $3.28B invested in CRISPR Therapeutics in 2022 Q2 according to their latest regulatory filings, with 59 funds opening new positions, 124 increasing their positions, 122 reducing their positions, and 62 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
433
Holders Change
-11
Holders Change %
-2.48%
% of All Funds
7.32%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.08%
New
59
Increased
124
Reduced
122
Closed
62
Calls
$193M
Puts
$182M
Net Calls
+$10.4M
Net Calls Change
+$17.4M
Name Holding Trade Value Shares
Change
Shares
Change %
VVP
376
Venture Visionary Partners
Ohio
$3.04K +$3.04K +50 New
QCG
377
Quadrant Capital Group
Ohio
$3K -$6.53K -111 -69%
LFA
378
Level Financial Advisors
New York
$3K
First Manhattan
379
First Manhattan
New York
$3K
TFA
380
Toth Financial Advisory
Virginia
$3K
MS
381
Mizuho Securities
Japan
$3K
WBC
382
West Branch Capital
Massachusetts
$3K
GRP
383
Global Retirement Partners
California
$3K
MWA
384
Moser Wealth Advisors
Washington
$3K
TFP
385
Tilia Fiduciary Partners
North Carolina
$3K
CMBA
386
C.M. Bidwell & Associates
Hawaii
$3K
BCMLT
387
Beacon Capital Management LLC (Tennessee)
Tennessee
$3K
CCMW
388
Cypress Capital Management (Wyoming)
Wyoming
$3K +$3K +50 New
WPA
389
West Paces Advisors
Georgia
$2.13K
GI
390
Gradient Investments
Minnesota
$2K -$3.04K -38 -60%
LC
391
Lindbrook Capital
California
$2K -$973 -18 -33%
ADL
392
Asset Dedication LLC
California
$2K
PP
393
Pacifica Partners
Canada
$2K
ME
394
McIlrath & Eck
Washington
$2K
GWSG
395
GPS Wealth Strategies Group
Colorado
$2K
KA
396
Kozak & Associates
Colorado
$2K
CA
397
Clearstead Advisors
Ohio
$2K +$500 +10 +33%
CMP
398
Coston McIsaac & Partners
Maine
$2K +$2K +25 New
AAP
399
Arax Advisory Partners
Colorado
$2K +$2K +40 New
TCWA
400
Ten Capital Wealth Advisors
Washington
$2K +$2K +40 New